Developing a range of products for US, EU markets: Aurobindo Pharma – ET HealthWorld

New Delhi: Drug major Aurobindo Pharma is developing a range of products including 14 biosimilars as it looks to expand its product portfolio in the US and EU markets, according to a top company official. The firm is developing eight inhalers and six nasal sprays, out of which two products have already been filed, Aurobindo […]